Accelerate Diagnostics (AXDX) Misses Q2 EPS by 50c

Accelerate Diagnostics (NASDAQ: AXDX) reported Q2 EPS of ($0.50). Revenue for the quarter came in at $3 million.

For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.

You May Also Be Interested In

• FICO (FICO) Tops Q3 EPS by 48c; raises guidance
• Aware, Inc. (AWRE) Reports Q2 Loss of $0.12
• Sturm Ruger (RGR) Tops Q2 EPS by 6c